Cover Image
Market Research Report

Europe Healthcare Analytics Market Forecast 2019-2027

Published by Inkwood Research Product code 728649
Published Content info 87 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Healthcare Analytics Market Forecast 2019-2027
Published: October 19, 2018 Content info: 87 Pages
Description

KEY FINDINGS

The CAGR for the European Healthcare analytics market is poised to grow at 27.03% between the forecast period of 2019-2027. The European healthcare system is facing similar challenges as the rest of the world, which includes controlling costs, managing population health and chronic diseases.

MARKET INSIGHTS

Collection of data is easier in single-payer systems which are predominantly available in Europe. Due to this, standardization and system interoperability issues are much smaller than in healthcare systems in other developed markets like the United States. However, government budget cuts due to the economic crisis have limited the resources available to fund health care and the willingness to pay for big data and analytics. This is a major reason for slower market growth. Being a fragmented and price sensitive market, there are also fewer incentives.

COMPETITIVE INSIGHTS

Prominent companies involved in the European healthcare analytics market are Cerner Corp, Allscripts, Healthcare Solutions Inc., Verisk Analytics, Elsevier B.V., Health, Catalyst, IBM Corp, Mckesson Corp, Medeanalytics, Mckesson Corp Optum Inc. (Part Of Unitedhealth Group Inc.), Sas Institute Inc and Oracle Corporation.

Table of Contents
Product Code: 22283

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. SERVICES COMPONENT TYPE HOLDS THE LARGEST MARKET SHARE
    • 3.2.2. ON-PREMISE DELIVERY MODE IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
    • 3.2.3. CLINICAL ANALYTICS IS THE MAJORLY USED APPLICATION
    • 3.2.4. PROVIDER IS THE FASTEST GROWING END USER

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. RISING ADOPTION OF CONNECTED DEVICES IN HEALTHCARE SECTOR
    • 4.1.2. OPTIMIZING CLINICAL OUTCOMES
    • 4.1.3. TECHNOLOGICAL ADVANCEMENT
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. UNAVAILABILITY OF SKILLED PROFESSIONALS
    • 4.2.2. RELUCTANCE ON THE PART OF THE MEDICAL COMMUNITY TO ACCEPT THE IT-BASED APPROACH
    • 4.2.3. UNSTRUCTURED HEALTH ORGANIZATION DATA
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. INCREASING DATA VOLUMES
    • 4.3.2. RELY ON ANALYTICS TO DELIVER THE HIGHEST QUALITY OF CARE
    • 4.3.3. POTENTIAL USAGE OF LARGE HEALTH DATASETS
    • 4.3.4. INCREASING DEMAND FOR GREATER INFORMATION EXCHANGE
    • 4.3.5. EMERGENCY CARE AND PREVENTIVE CARE
    • 4.3.6. DETECT, IDENTIFY AND REDUCE FRAUD
  • 4.4. MARKET CHALLENGES
    • 4.4.1. OVERCOMING FINANCIAL CONSTRAINTS
    • 4.4.2. INCREASED USE OF AUTOMATED TECHNOLOGIES
    • 4.4.3. CONTINUED USE OF EXISTING BASIC ANALYTICS TOOLS

5. MARKET SEGMENTATION

  • 5.1. MARKET BY COMPONENT TYPE 2019-2027
    • 5.1.1. SERVICES
    • 5.1.2. SOFTWARE
    • 5.1.3. HARDWARE
  • 5.2. MARKET BY DELIVERY MODE 2019-2027
    • 5.2.1. ON-DEMAND
    • 5.2.2. ON-PREMISE
  • 5.3. MARKET BY APPLICATION 2019-2027
    • 5.3.1. CLINICAL ANALYTICS
      • 5.3.1.1. CLINICAL DECISION SUPPORT
      • 5.3.1.2. QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING
      • 5.3.1.3. REGULATORY REPORTING AND COMPLIANCE
      • 5.3.1.4. COMPARATIVE ANALYTICS/COMPARATIVE EFFECTIVENESS
      • 5.3.1.5. PRECISION HEALTH
    • 5.3.2. FINANCIAL ANALYTIC
      • 5.3.2.1. REVENUE CYCLE MANAGEMENT (RCM)
      • 5.3.2.2. CLAIMS ANALYTICS
      • 5.3.2.3. PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA)
      • 5.3.2.4. RISK MANAGEMENT ANALYTICS
    • 5.3.3. OPERATIONAL AND ADMINISTRATIVE ANALYTICS
      • 5.3.3.1. WORKFORCE ANALYTICS
      • 5.3.3.2. SUPPLY CHAIN ANALYTICS
      • 5.3.3.3. STRATEGIC ANALYTICS
    • 5.3.4. POPULATION HEALTH ANALYTICS
  • 5.4. MARKET BY END USERS 2019-2027
    • 5.4.1. PAYER
      • 5.4.1.1. EMPLOYERS AND PRIVATE EXCHANGES
      • 5.4.1.2. GOVERNMENT AGENCIES
      • 5.4.1.3. PRIVATE INSURANCE COMPANIES
    • 5.4.2. PROVIDER
      • 5.4.2.1. HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
      • 5.4.2.2. POST-ACUTE CARE ORGANIZATIONS
      • 5.4.2.3. AMBULATORY SETTINGS
    • 5.4.3. ACOS, HIES, MCOS, AND TPAS

6. KEY ANALYTICS

  • 6.1. STAKEHOLDERS OF HEALTH CARE INDUSTRY
  • 6.2. ANALYTICS TYPE
  • 6.3. HEALTHCARE BIG DATA
  • 6.4. DEPLOYMENT MODELS IN HEALTHCARE ANALYTICS
  • 6.5. KEY FACTORS IN HEALTHCARE INDUSTRY
  • 6.6. OPPORTUNITY MATRIX
  • 6.7. LEGAL, POLICY & REGULATORY FRAMEWORK

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. THE UNITED KINGDOM
    • 7.1.2. FRANCE
    • 7.1.3. GERMANY
    • 7.1.4. RUSSIA
    • 7.1.5. REST OF EUROPE

8. COMPANY PROFILES

  • 8.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
    • 8.1.1. COMPANY OVERVIEW
    • 8.1.2. PRODUCT PORTFOLIO
    • 8.1.3. SCOT ANALYSIS
    • 8.1.4. STRATEGIC INITIATIVES
  • 8.2. CERNER CORP.
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. SCOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. ELSEVIER B.V.
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. STRATEGIC INITIATIVES
  • 8.4. HEALTH CATALYST
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. STRATEGIC INITIATIVES
  • 8.5. IBM CORP.
    • 8.5.1. OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. SCOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. MCKESSON CORP
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCT PORTFOLIO
    • 8.6.3. SCOT ANALYSIS
    • 8.6.4. STRATEGIC INITIATIVES
  • 8.7. MEDEANALYTICS
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. STRATEGIC INITIATIVES
  • 8.8. MCKESSON CORP OPTUM INC. (PART OF UNITEDHEALTH GROUP INC.)
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. STRATEGIC INITIATIVES
  • 8.9. ORACLE CORPORATION
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCT PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVES
  • 8.10. SAS INSTITUTE INC.
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. SCOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVES
  • 8.11. VERISK ANALYTICS
    • 8.11.1. COMPANY OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. SCOT ANALYSIS
    • 8.11.4. STRATEGIC INITIATIVES

LIST OF TABLES

  • TABLE 1 EUROPE HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • TABLE 2 EUROPE HEALTHCARE ANALYTICS MARKET BY COMPONENT TYPE 2019-2027 ($ MILLION)
  • TABLE 3 EUROPE HEALTHCARE ANALYTICS MARKET IN SERVICES 2019-2027 ($ MILLION)
  • TABLE 4 EUROPE HEALTHCARE ANALYTICS MARKET IN SOFTWARE 2019-2027 ($ MILLION)
  • TABLE 5 EUROPE HEALTHCARE ANALYTICS MARKET IN HARDWARE 2019-2027 ($ MILLION)
  • TABLE 6 EUROPE HEALTHCARE ANALYTICS MARKET BY DELIVERY MODE 2019-2027 ($ MILLION)
  • TABLE 7 EUROPE HEALTHCARE ANALYTICS MARKET IN ON-DEMAND 2019-2027 ($ MILLION)
  • TABLE 8 EUROPE HEALTHCARE ANALYTICS MARKET IN ON-PREMISE 2019-2027 ($ MILLION)
  • TABLE 9 EUROPE HEALTHCARE ANALYTICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 10 HEALTHCARE ANALYTICS APPLICATION-BASED DATA
  • TABLE 11 EUROPE HEALTHCARE ANALYTICS MARKET BY IN CLINICAL ANALYTICS BY TYPES 2019-2027 ($ MILLION)
  • TABLE 12 EUROPE HEALTHCARE ANALYTICS MARKET IN CLINICAL ANALYTICS 2019-2027 ($ MILLION)
  • TABLE 13 EUROPE CLINICAL ANALYTICS MARKET IN CLINICAL DECISION SUPPORT 2019-2027 ($ MILLION)
  • TABLE 14 EUROPE CLINICAL ANALYTICS MARKET IN QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 2019-2027 ($ MILLION)
  • TABLE 15 EUROPE CLINICAL ANALYTICS MARKET IN REGULATORY REPORTING AND COMPLIANCE 2019-2027 ($ MILLION)
  • TABLE 16 EUROPE CLINICAL ANALYTICS MARKET IN COMPARATIVE ANALYTICS/COMPARATIVE EFFECTIVENESS 2019-2027 ($ MILLION)
  • TABLE 17 EUROPE CLINICAL ANALYTICS MARKET IN PRECISION HEALTH 2019-2027 ($ MILLION)
  • TABLE 18 EUROPE HEALTHCARE ANALYTICS MARKET BY IN FINANCIAL ANALYTIC BY TYPES 2019-2027 ($ MILLION)
  • TABLE 19 EUROPE HEALTHCARE ANALYTICS MARKET IN FINANCIAL ANALYTIC 2019-2027 ($ MILLION)
  • TABLE 20 EUROPE FINANCIAL ANALYTIC MARKET IN REVENUE CYCLE MANAGEMENT (RCM) 2019-2027 ($ MILLION)
  • TABLE 21 EUROPE FINANCIAL ANALYTIC MARKET IN CLAIMS ANALYTICS 2019-2027 ($ MILLION)
  • TABLE 22 EUROPE FINANCIAL ANALYTIC MARKET IN PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA) 2019-2027 ($ MILLION)
  • TABLE 23 EUROPE FINANCIAL ANALYTIC MARKET IN RISK MANAGEMENT ANALYTICS 2019-2027 ($ MILLION)
  • TABLE 24 EUROPE HEALTHCARE ANALYTICS MARKET BY IN OPERATIONAL AND ADMINISTRATIVE ANALYTICS BY TYPES 2019-2027 ($ MILLION)
  • TABLE 25 EUROPE HEALTHCARE ANALYTICS MARKET IN OPERATIONAL AND ADMINISTRATIVE ANALYTICS 2019-2027 ($ MILLION)
  • TABLE 26 EUROPE OPERATIONAL AND ADMINISTRATIVE ANALYTICS MARKET IN 2019-2027 ($ MILLION)
  • TABLE 27 EUROPE OPERATIONAL AND ADMINISTRATIVE ANALYTICS MARKET IN 2019-2027 ($ MILLION)
  • TABLE 28 EUROPE OPERATIONAL AND ADMINISTRATIVE ANALYTICS MARKET IN 2019-2027 ($ MILLION)
  • TABLE 29 EUROPE HEALTHCARE ANALYTICS MARKET IN POPULATION HEALTH ANALYTICS 2019-2027 ($ MILLION)
  • TABLE 30 EUROPE HEALTHCARE ANALYTICS MARKET BY END USERS 2019-2027 ($ MILLION)
  • TABLE 31 EUROPE HEALTHCARE ANALYTICS MARKET IN PAYER 2019-2027 ($ MILLION)
  • TABLE 32 EUROPE HEALTHCARE ANALYTICS MARKET IN PAYER BY TYPES 2019-2027 ($ MILLION)
  • TABLE 33 EUROPE PAYER MARKET IN EMPLOYERS AND PRIVATE EXCHANGES 2019-2027 ($ MILLION)
  • TABLE 34 EUROPE PAYER MARKET IN GOVERNMENT AGENCIES 2019-2027 ($ MILLION)
  • TABLE 35 EUROPE PAYER MARKET IN PRIVATE INSURANCE COMPANIES 2019-2027 ($ MILLION)
  • TABLE 36 EUROPE HEALTHCARE ANALYTICS MARKET IN PROVIDER 2019-2027 ($ MILLION)
  • TABLE 37 EUROPE HEALTHCARE ANALYTICS MARKET IN PROVIDER BY TYPE 2019-2027 ($ MILLION)
  • TABLE 38 CLAIMS AND EMR DATA
  • TABLE 39 EUROPE PROVIDER TYPE MARKET IN HOSPITALS, PHYSICIAN PRACTICES, AND IDNS 2019-2027 ($ MILLION)
  • TABLE 40 EUROPE PROVIDER TYPE MARKET IN POST-ACUTE CARE ORGANIZATIONS 2019-2027 ($ MILLION)
  • TABLE 41 EUROPE PROVIDER TYPE MARKET IN AMBULATORY SETTINGS 2019-2027 ($ MILLION)
  • TABLE 42 EUROPE HEALTHCARE ANALYTICS MARKET IN ACOS, HIES, MCOS AND TPAS 2019-2027 ($ MILLION)
  • TABLE 43 ATTRIBUTES OF BIG DATA IN HEALTHCARE
  • TABLE 44 DEPLOYMENT MODELS FOR ANALYTICS
  • TABLE 45 EUROPE HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 THE UNITED KINGDOM HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 3 FRANCE HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 4 GERMANY HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 5 RUSSIA HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 6 ITALY HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 7 SPAIN HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 8 REST OF EUROPE HEALTHCARE ANALYTICS MARKET 2019-2027 ($ MILLION)
Back to Top